Etikasari R, Andayani T, Endarti D, Taroeno-Hariadi K. The 5-Year Disease-Free Survival of Third Generation Aromatase Inhibitor for Postmenopausal Women with HR-positive HER2-negative Non-Metastatic Breast Cancer. Int J Hematol Oncol Stem Cell Res. 2023;17(1):48-55.